US-based Vertex Pharmaceuticals has agreed to pay approximately $4.9 billion in cash to acquire Alpine Immune Sciences, a compatriot biotechnology company focused on...
13.06.2017
- US drugmaker Merck has signed a partnership agreement with UK biotech F-star to develop and commercialize five of the Cambridge-headquartered company’s novel bispecific immuno...
